Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs

BACKGROUND: Decisions relating to the funding of new drugs are becoming increasingly challenging due to a combination of aging populations, rapidly increasing list prices, and greater numbers of drug-indication pairs being brought to market. This is especially true in cancer, where rapid list price...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Public Health
Hlavní autoři: Costa, Sarah, Bentley, Colene, Regier, Dean A., McTaggart-Cowan, Helen, Mitton, Craig, Burgess, Michael M., Peacock, Stuart J.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6647147/
https://ncbi.nlm.nih.gov/pubmed/31331312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-019-7303-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky